โš  LIVE โ€” European Consumer Safety Watch ๐Ÿ’Š Medicines: 15 in last 7 days ๐ŸŽ Food: 1 in last 7 days ๐Ÿงธ Products: 52 in last 7 days ๐ŸŸข Monitoring: EMA ยท RASFF ยท NVWA ยท FAGG ยท FAVV ยท EFSA ยท Safety Gate โฑ Last fetch: 2 hours ago โš  LIVE โ€” European Consumer Safety Watch ๐Ÿ’Š Medicines: 15 in last 7 days ๐ŸŽ Food: 1 in last 7 days ๐Ÿงธ Products: 52 in last 7 days ๐ŸŸข Monitoring: EMA ยท RASFF ยท NVWA ยท FAGG ยท FAVV ยท EFSA ยท Safety Gate โฑ Last fetch: 2 hours ago
๐Ÿ›ก๏ธ EUSW
๐Ÿ‡ฌ๐Ÿ‡ง
๐Ÿ’Š

Integrilin

eptifibatide
Angina, Unstable;Myocardial Infarction
๐Ÿšซ Withdrawn

What it's used for

Integrilin is intended for use with acetylsalicylic acid and unfractionated heparin. Integrilin is indicated for the prevention of early myocardial infarction in patients presenting with unstable angina or non-Q-wave myocardial infarction with the last episode of chest pain occurring within 24 hours and with ECG changes and / or elevated cardiac enzymes. Patients most likely to benefit from Integrilin treatment are those at high risk of developing myocardial infarction within the first 3-4 days after onset of acute angina symptoms including for instance those that are likely to undergo an early percutaneous transluminal coronary angioplasty (PTCA).

โš ๏ธ Patient safety

No

๐Ÿ“š Past alerts (1)
โš ๏ธ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.